newsfilter
← Latest News
GlobeNewswire·

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update Announced exclusive option and license agreement with Takeda for ACI-24.060 on May 13 for $100 million upfront and total potential